Generate Biomedicines (GENB)
Builds protein therapeutics through a closed-loop generative-biology platform.
$16.30
Pre-market+0.03 (+0.18%)
At close$16.27(+3.04%)
Something off on this page? Send us feedback.
Next report
Nov 5, 2026
estimated · in 63 days
EPS estimate
−$0.51
Revenue estimate
$7.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
——————Aug '26Nov '26
Reported——————−$0.52Pending
Estimate——————−$0.51−$0.51
Surprise——————−2.3%—
RevenueReportedEstimate
——————Aug '26Nov '26
Reported——————$6.3MPending
Estimate——————$5.3M$7.8M
Surprise——————+19.1%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.51 | — | — |
| Aug 2026 | −$0.51 | −$0.52 | −2.3% |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.51 | — | — | $7.8M | — | — | — |
| Aug 6, 2026 | −$0.51 | −$0.52 | −2.3% | $5.3M | $6.3M | +19.1% | −4.1% |